OPSONIX

Opsonix is developing and commercializing a pathogen-extracting therapy that uses its proprietary pathogen-capture proteins to remove infectious microbes and the toxins they release from circulating blood, offering a new broad-spectrum approach to transform the treatment of blood-borne infectious diseases, including sepsis.

#SimilarOrganizations #People #Financial #Website #More

OPSONIX

Industry:

Biotechnology Health Care Medical Therapeutics

Founded:

2014-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.opsonixbio.com

Total Employee:

1+

Status:

Active

Contact:

Email Addresses:

[email protected]

Total Funding:

9.25 M USD

Technology used in webpage:

Domain Not Resolving

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

Current Employees Featured

michael-super_image

Michael Super
Michael Super Scientific Founder @ Opsonix
Scientific Founder

not_available_image

Hansjörg Wyss
Hansjörg Wyss CEO @ Opsonix
CEO

donald-ingber_image

Donald Ingber
Donald Ingber Scientific Founder @ Opsonix
Scientific Founder

Founder

donald-ingber_image

Donald Ingber

eric-devroe_image

Eric Devroe

michael-super_image

Michael Super

Investors List

baxter-ventures_image

Baxter Ventures

Baxter Ventures investment in Series A - Opsonix

Official Site Inspections

http://www.opsonixbio.com

Host Informations
Whois Informations

Loading ...

More informations about "Opsonix" on Search Engine